Clene Statistics
Total Valuation
Clene has a market cap or net worth of $42.51 million. The enterprise value is $46.98 million.
| Market Cap | 42.51M |
| Enterprise Value | 46.98M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Clene has 128.43 million shares outstanding. The number of shares has increased by 68.87% in one year.
| Shares Outstanding | 128.43M |
| Shares Change (YoY) | +68.87% |
| Shares Change (QoQ) | +22.38% |
| Owned by Insiders (%) | 33.29% |
| Owned by Institutions (%) | 15.90% |
| Float | 66.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 68.57 |
| Forward PS | 109.68 |
| PB Ratio | 9.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 75.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 7.61.
| Current Ratio | 1.23 |
| Quick Ratio | 1.07 |
| Debt / Equity | 7.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.31 |
Financial Efficiency
Return on equity (ROE) is -322.20% and return on invested capital (ROIC) is -106.36%.
| Return on Equity (ROE) | -322.20% |
| Return on Assets (ROA) | -86.50% |
| Return on Capital (ROIC) | -106.36% |
| Revenue Per Employee | $7,561 |
| Profits Per Employee | -$595,293 |
| Employee Count | 82 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.95% in the last 52 weeks. The beta is 0.45, so Clene's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -61.95% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.42 |
| Relative Strength Index (RSI) | 39.46 |
| Average Volume (20 Days) | 627,391 |
Short Selling Information
The latest short interest is 333,388, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 333,388 |
| Short Previous Month | 596,514 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, Clene had revenue of $620,000 and -$48.81 million in losses. Loss per share was -$0.46.
| Revenue | 620,000 |
| Gross Profit | 488,000 |
| Operating Income | -39.04M |
| Pretax Income | -48.81M |
| Net Income | -48.81M |
| EBITDA | -41.91M |
| EBIT | -44.08M |
| Loss Per Share | -$0.46 |
Balance Sheet
The company has $27.97 million in cash and $32.44 million in debt, giving a net cash position of -$4.47 million or -$0.03 per share.
| Cash & Cash Equivalents | 27.97M |
| Total Debt | 32.44M |
| Net Cash | -4.47M |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | 4.26M |
| Book Value Per Share | 0.03 |
| Working Capital | 5.93M |
Cash Flow
In the last 12 months, operating cash flow was -$28.04 million and capital expenditures -$63,000, giving a free cash flow of -$28.10 million.
| Operating Cash Flow | -28.04M |
| Capital Expenditures | -63,000 |
| Free Cash Flow | -28.10M |
| FCF Per Share | -$0.22 |
Margins
Gross margin is 78.71%, with operating and profit margins of -6,296.77% and -7,873.23%.
| Gross Margin | 78.71% |
| Operating Margin | -6,296.77% |
| Pretax Margin | -7,873.23% |
| Profit Margin | -7,873.23% |
| EBITDA Margin | -6,759.19% |
| EBIT Margin | -7,109.35% |
| FCF Margin | -4,531.94% |
Dividends & Yields
Clene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -68.87% |
| Shareholder Yield | -68.87% |
| Earnings Yield | -114.82% |
| FCF Yield | -66.09% |
Analyst Forecast
The average price target for Clene is $6.50, which is 1,863.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 1,863.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 243.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Dec 31, 2020 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
Clene has an Altman Z-Score of -10.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.31 |
| Piotroski F-Score | 2 |